Improving the use of heart and kidney medications in veterans with kidney disease
Official title: Optimizing Renin Angiotensin System Blocker Use among Veterans with Kidney Disease
Funded at Michael E Debakey VA Medical Center · NIH-11175239 · Data updated 2026-11-12
This study is looking at how to better help veterans with chronic kidney disease get the heart medications they need, by figuring out why some aren’t receiving them and creating tools for doctors to make it easier to start or restart these treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michael E Debakey VA Medical Center NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | October 1, 2020 |
| Project end | September 30, 2025 |
| Funding year | 2025 |
| NIH project number | 5I01HX002917-05 |
| Project ID | NIH-11175239 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are veterans diagnosed with chronic kidney disease who may benefit from ACEI or ARB medications.
✕Less likely to help
Patients who are not veterans or those without chronic kidney disease may not receive any benefit from this research.
What this research studies
This research investigates how to optimize the use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) among veterans suffering from chronic kidney disease (CKD). It aims to identify why a significant number of veterans are not receiving these essential medications, focusing on factors such as side effects and clinical inertia. By analyzing structured datasets and provider notes, the study will develop a communication aid to help healthcare teams initiate or resume ACEI/ARB therapy in CKD patients. The goal is to enhance patient care and improve health outcomes for veterans with kidney disease.
Why it matters
Potential benefit: If successful, this research could lead to better management of kidney disease in veterans, potentially reducing the need for dialysis and improving overall survival rates.
How similar studies have gone: Previous research has shown that optimizing medication use in chronic disease management can lead to significant improvements in patient outcomes, suggesting that this approach may be effective.
Where this research is happening
-
Michael E Debakey VA Medical Center
Houston, United States Active
Researchers
- Principal investigator: Navaneethan, Sankar Dass — Michael E Debakey VA Medical Center
- Study coordinator: Navaneethan, Sankar Dass
Related research
Other NIH-funded projects on the same topics.
-
Personalized CKD-MBD care using systems biology and AI
A patient-facing program aims to tailor mineral-balance therapy for people with chronic kidney disease by using a computer model and smart decision rules to predict who will respond best to treatments.
-
Mitigating DKA in people with type 1 diabetes and kidney disease using SGLT1/2 inhibitors
This project tests a new way to prevent dangerous diabetic ketoacidosis in people with type 1 diabetes and chronic kidney disease who are using SGLT inhibitors, by tracking ketones in real time and combining glucose-keton data for safer therapy.
-
Chronic Kidney Disease in Children: following young people as they grow up with CKD
A long-term study in kids with chronic kidney disease tracks kidney function and heart health as they transition into adulthood.
-
Chronic Kidney Disease in Children follow-up study
A long-term study that follows kids with kidney disease as they grow into young adults, collecting health data from home and official records.
-
KDARC: Building a research backbone to study aging and kidney disease
Aimed at creating a dedicated infrastructure to advance aging-related kidney disease research so clinicians can better care for older adults.
-
Malaria-related kidney injury and its link to chronic kidney disease in children
This grant looks at why some children who have malaria develop kidney injury and later chronic kidney disease, focusing on how severe malaria affects the kidneys over time.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.